Literature DB >> 2501063

Anticardiolipin antibodies in patients with infectious diseases.

M B Santiago1, W Cossermelli, M F Tuma, M N Pinto, R M Oliveira.   

Abstract

IgG or IgM anticardiolipin antibodies were present in the sera of 67% of 33 patients with Hansen's disease, in 53% of 30 patients with tuberculosis and in 50% of 16 patients with endocarditis. Despite the high frequency of these antibodies, no patient had a history of thrombosis or abortion. Anti-denatured DNA antibodies were tested in patients with tuberculosis and patients with Hansen's disease. Only in the latter group did we observe a statistically significant association between anticardiolipin and anti-denatured DNA antibodies. Anticardiolipin binding activity, however, could not be inhibited by preincubation of sera with a variable concentration of denatured DNA. These data suggest that: a) Anticardiolipin antibodies in infectious diseases do not necessarily participate in the pathogenesis of thrombotic or obstetric complications; b) Anti-denatured DNA and anticardiolipin antibodies in the population studied do not have a cross-reaction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501063     DOI: 10.1007/bf02031064

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

Review 1.  Origins of anti-DNA autoantibodies.

Authors:  R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

2.  Anticardiolipin response in acute infections.

Authors:  O Vaarala; T Palosuo; M Kleemola; K Aho
Journal:  Clin Immunol Immunopathol       Date:  1986-10

3.  Evaluation of anti-cardiolipin antibody and its cross-reactivity in sera of patients with lepromatous leprosy.

Authors:  F Furukawa; M Kashihara; S Imamura; G Ohshio; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

4.  Anticardiolipin antibodies in pregnancy.

Authors:  J G Thornton; J S Scott; L A Tovey
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

5.  "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.

Authors:  L O Carreras; J G Vermylen
Journal:  Thromb Haemost       Date:  1982-08-24       Impact factor: 5.249

6.  Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal.

Authors:  R A Asherson; J K Chan; E N Harris; A E Gharavi; G R Hughes
Journal:  Ann Rheum Dis       Date:  1985-12       Impact factor: 19.103

7.  Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test.

Authors:  E N Harris; J K Chan; R A Asherson; V R Aber; A E Gharavi; G R Hughes
Journal:  Arch Intern Med       Date:  1986-11

8.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

Authors:  A E Gharavi; E N Harris; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

9.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

10.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Authors:  M D Lockshin; M L Druzin; S Goei; T Qamar; M S Magid; L Jovanovic; M Ferenc
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

  10 in total
  13 in total

1.  Isolated hepatic tuberculoma after orthotopic liver transplantation: a case report.

Authors:  Annalisa Berzigotti; Giampaolo Bianchi; Susanna Dapporto; Antonio Daniele Pinna; Marco Zoli
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Endoscopically removed hepatolithiasis associated with cavernous transformation of the portal vein and antiphospholipid antibody syndrome.

Authors:  Keisuke Okudaira; Atsushi Kawaguchi; Takuya Inoue; Kazutoshi Hashiguchi; Yoshikazu Tsuzuki; Shigeaki Nagao; Kazuro Itoh; Soichiro Miura
Journal:  Dig Dis Sci       Date:  2006-10-24       Impact factor: 3.199

3.  Relation between serological data at the time of biopsy and renal histology in lupus nephritis.

Authors:  J C Nossent; S C Henzen-Logmans; T M Vroom; V Huysen; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

4.  Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population.

Authors:  A O Adebajo; P Charles; R N Maini; B L Hazleman
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

5.  A "primary" thrombotic syndrome: absence of anti-phospholipid antibodies.

Authors:  J Sabbaga; J F Neto; R Chaddad; I Cecconello; R M De Oliveira
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

6.  Prevalence of antiphospholipid antibodies in Chilean patients with rheumatoid arthritis.

Authors:  Iván Palomo; Carmen Pinochet; Marcelo Alarcón; Rodrigo Sandoval; Jaime Gonzalez; Francisco Monsalves; Ricardo Forastiero
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

7.  Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.

Authors:  E S Vista; S R Crowe; L F Thompson; G M Air; J M Robertson; J M Guthridge; J A James
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

8.  Antiphospholipid antibodies in HIV-positive patients.

Authors:  Liliana Galrão; Carlos Brites; Maria Luíza Atta; Ajax Atta; Isabella Lima; Fernanda Gonzalez; Fernanda Magalhães; Mittermayer Santiago
Journal:  Clin Rheumatol       Date:  2007-02-28       Impact factor: 2.980

9.  Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus.

Authors:  T Sitter; M Spannagl; H Schiffl
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673

10.  Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients.

Authors:  Iván Palomo; Marcelo Alarcón; Cecilia Sepulveda; Jaime Pereira; Ricardo Espinola; Silvia Pierangeli
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.